Strong immunohistochemical staining for HER2 protein has also been identified in 25–92% of SDCs (5). These findings highlight the similarity between SDC and breast cancer with regard not only to the overall morphology but also the immunophenotype and gene expression profile. This evidence concerns the gene ERBB2 and breast cancer.